Breaking News

PharmaZell Continues API Expansion in India

cGMP kilo expansion at Vizag site follows two previous boosts.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PharmaZell GmbH has expanded its manufacturing capabilities in India. The company has completed construction of a cGMP kilo-lab at its R&D center in Vizag, India. This follows two other recent expansions in India. In 2007, PharmaZell built a commercial production plant in Vizag, India to produce the API, Mesalamine. In 2008, PharmaZell continued expanding in Vizag by building an R&D facility that now employs approximately 35 chemists focused on chemical route and process development, ana...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters